Lincoln International Represents Nature’s Way Products, Inc. in its Acquisition of Enzymatic Therapy, Inc.
New York, November 4, 2008 – Lincoln International, a leading global middle-market investment bank, today announced the acquisition of Enzymatic Therapy, Inc. (“Enzymatic”) from North Castle Partners, LLC, a Greenwich-based private equity firm, by Nature’s Way Holding Company (“Nature’s Way”), a wholly owned subsidiary of German-based Dr. Willmar Schwabe Pharmaceuticals (“Schwabe”).
Enzymatic is a leading developer, manufacturer and marketer of highly efficacious natural medicines. Located in Green Bay, Wisconsin, Enzymatic has established several strong brand name products, including Enzymatic Therapy™, PhytoPharmica™, Integrative Therapeutics™ and Remifemin™.
The combination of Enzymatic and Nature’s Way creates an unsurpassed portfolio of clinically validated natural products and ingredients. Lincoln International acted as the exclusive financial advisor to Schwabe and Nature’s Way.
Lincoln International worked closely with the Board of Directors and senior management teams of Nature’s Way and Schwabe throughout the acquisition process, from initial evaluation of the opportunity through final due diligence and negotiating the final terms of the transaction.
“Lincoln was a very valuable asset to Nature’s Way and Schwabe. Their extensive analysis, timely advice and persistence throughout the process helped achieve a great outcome for Nature’s Way. Enzymatic has had a great track record under North Castle, and we look forward to welcoming Enzymatic, its customers and employees to the Nature’s Way organization.” said Dr. Dirk Reischig, President of Nature's Way.
About Nature’s Way
Nature's Way was founded in 1968, and has improved the life of millions of consumers by bringing the healing power of nature through herbal formulations. Nature's Way is headquartered in Springville, Utah, and its products are sold throughout leading natural products retailers throughout the United States and in 40 other countries.
About Dr. Willmar Schwabe Pharmaceuticals
Dr. Willmar Schwabe Pharmaceuticals, headquartered in Karlsruhe, Germany, was founded in 1866. Today, the group is a world-class leader in the manufacturing of herbal medicines and comprises six companies in Germany and more than 20 subsidiaries and joint ventures around the world. For more than 140 years, Schwabe Pharmaceuticals has been dedicated to providing patients and health care professionals with clinically proven herbal medicines and natural health care solutions.
About Lincoln International
Lincoln International specializes in mergers and acquisitions advisory services, debt advisory services, UK pension advisory services, fairness opinions and valuations, corporate finance issues, and financial restructurings / special situations for leading organizations involved in mid-market transactions. With offices in Chicago, Frankfurt, London, Los Angeles, Madrid, New York, Paris, Tokyo and Vienna, and strategic partnerships with firms in China and India, Lincoln International has strong local knowledge and contacts in the key global economies. Our organization provides clients with senior-level attention, in-depth industry expertise and integrated resources. By being focused and independent, Lincoln International serves its clients without conflicts of interest. Additional information can also be found at www.lincolninternational.com.
| back |